Location History:
- Utrecht, NL (2012 - 2015)
- Leiden, NL (2018)
Company Filing History:
2 out of 24 
1 out of 832,812 Years Active: 2012-2018
Title: Robert Passier: Innovator in Cardiomyocyte Differentiation
Introduction
Robert Passier is a prominent inventor based in Utrecht, Netherlands, known for his significant contributions to the field of regenerative medicine. With a total of three patents to his name, Passier's work focuses on the differentiation of human embryonic stem cells into cardiomyocytes, which is crucial for developing therapies for cardiac diseases.
Latest Patents
One of Robert Passier's most recent patents involves a method for testing a factor for cardiogenicity. This invention details a process where human embryonic stem (hES) cells are differentiated into cardiomyocytes both in the presence and absence of a specified factor. The method requires culturing hES cells under serum-free conditions, using co-culture with END-2 cells or serum-free extracellular medium, followed by measuring differentiation outcomes. Furthermore, this patent also provides a systematic approach to identifying cardiogenic factors that influence this process, enhancing the understanding of cardiac development.
Another notable aspect of his work in cardiomyocyte differentiation emphasizes the same methodology for testing cardiogenic factors. This dual approach not only innovates how such factors are tested but also serves to refine the identification methods applicable in regenerative medicine.
Career Highlights
Throughout his career, Robert Passier has been associated with various institutions that focus on cutting-edge research in stem cell technology. He notably worked for Es Cell International Pte Ltd, contributing to pioneering research that seeks to translate stem cell science into therapeutic solutions.
Collaborations
Robert has had the privilege of collaborating with Christine Lindsay Mummery, a respected figure in the field of development and regenerative biology. Their partnership underscores a mutual commitment to advancing the understanding of stem cell differentiation processes.
Conclusion
In summary, Robert Passier stands out as an innovative inventor whose work is paving the way for new therapies in cardiovascular medicine. With his expertise in cardiomyocyte differentiation and significant collaborations, Passier continues to contribute to the scientific community, making strides that could ultimately transform patient care in cardiac health.